• Home
  • About
    • Company Overview
    • Management Team
    • Board of Directors
    • Investors
  • Aspergillosis
  • PC945
  • News
  • Contact
Pulmocide presented at European Respiratory Society 2016 in London, UK

Pulmocide gave an oral presentation (as a late breaking abstract) at European respiratory society annual meeting 2016, held September 03 – 07, 2016 in London, UK. This is as follows: […]

04 October 2016

Read more

Pulmocide present at the Macrae Foundation’s XVIII International Symposium

Pulmocide presented two posters at the Macrae Foundation’s XVIII International Symposium on Respiratory Viral Infections, held March 31 – April 02, 2016 in Lisbon, Portugal. These are as follows:   […]

04 April 2016

Read more

Pulmocide present at the 7th Advances Against Aspergillosis Conference 2016

Pulmocide presented five posters at the recent 7th Advances Against Aspergillosis Conference in Manchester, and the meeting organisers published a Press Release about the work Pulmocide presented, stating: “Dr Kazuhiro Ito from Pulmocide, […]

07 March 2016

Read more

Pulmocide will present at the 7th Advances against Aspergillosis

Pulmocide will present biological profile of First-in-Class inhaled anti-fungal agent, PC945 and PC1244 on upcoming 7th Advances against Aspergillosis in Manchester UK held March 3rd – 5th. http://www.advancesagainstaspergillosis.org/2016/programme.htm

15 January 2016

Read more

  • «
  • ← Previous
  • 1
  • 2
  • 3

Categories

  • Company news
  • Events
  • Presentations And Publications
  • Product news
  • Uncategorised

Company Contact

Pulmocide Ltd
44 Southampton Buildings
London
WC2A 1AP

Tel: +44 203 763 9484
Email: admin@pulmocide.com

Visit Us
  • Sitemap
  • Cookie policy
© 2023 Pulmocide
Company Reg: 06182024   265 Strand London WC2R 1BH
Web Design Agency - Brandcast Media